AI assistant
Medpace Holdings, Inc. — Director's Dealing 2021
Sep 7, 2021
30442_dirs_2021-09-07_33e0f032-bc56-4273-a422-c06a6187e2a5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Medpace Holdings, Inc. (MEDP)
CIK: 0001668397
Period of Report: 2021-09-02
Reporting Person: Medpace Investors, LLC (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-09-02 | Common Stock | S | 30234 | $191.85 | Disposed | 5957806 | Direct |
| 2021-09-03 | Common Stock | S | 604 | $191.82 | Disposed | 5957202 | Direct |
Footnotes
F1: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2021.
F2: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $186.49 to $194.04. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.
F3: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $190.76 to $192.87. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.